A recent study published in the Annals of Internal Medicine suggests that statins, commonly used to treat high cholesterol, may significantly reduce the risk of death and major cardiovascular events in adults with type 2 diabetes. The research, which analyzed data from people in the UK, indicates these benefits extend even to individuals predicted to be at low cardiovascular risk. The findings challenge previous assumptions and suggest clinicians should consider statin use for all type 2 diabetes patients, regardless of short-term risk assessment.